⌘K

Login Start Free

Home/Filings/4/0001144204-17-005183

4//SEC Filing

Caladrius Biosciences, Inc. 4

Accession 0001144204-17-005183

$LSTACIK 0000320017operating

View on SEC.gov Company Profile

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 6:51 PM ET

Size

9.7 KB

Accession

0001144204-17-005183

Insider Transaction Report

Form 4

Period: 2017-01-09

Caladrius Biosciences, Inc.CLBS

Director

Transactions

Award
Common Stock
2017-01-09+1,650→ 33,594 total
Award
Options to Purchase Common Stock
2017-01-09+2,750→ 2,750 total
Exercise: $3.54From: 2018-01-09Exp: 2027-01-09→ Common Stock (2,750 underlying)

Holdings

Common Stock
(indirect: By IRA)
8,434
Common Stock
(indirect: By Trust)
1,954
Common Stock
(indirect: By Spouse)
802

Footnotes (2)

[F1]Represents 1,650 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on January 9, 2018.
[F2]Includes 2,775 shares of unvested restricted stock granted under the Issuer's compensation plans.

Documents

1 file

4
v458002_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Caladrius Biosciences, Inc.

CIK 0000320017

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000320017

Filing Metadata

Form type: 4
Filed: Jan 30, 7:00 PM ET
Accepted: Jan 31, 6:51 PM ET
Size: 9.7 KB

View on SEC.gov